ArticlesCompetitive Benchmarking: How to Spot Gaps and Drive Smarter Growth
ArticlesDeloitte study: eight out of ten commercial real estate companies expect revenue growth in 2026
ArticlesTop 100 City Destinations Index 2025: Driving Growth and Innovation
ArticlesThe competitive advantage that transforms your business
Articles2026 consumer trends and industry insights [Webinar]
InterviewsPUTTING ROMANIAN CORPORATE COMPANIES ON THE INTERNATIONAL BUSINESS SCENE
InterviewsOUR EDGE WILL COME FROM BEING THE MOST DIGITALIZED WHOLESALER IN ROMANIA
InterviewsCOFFEE IS OUR LOVE LANGUAGE
InterviewsBUILDING THE FUTURE OF ENERGY: ENEVO GROUP’S ONE-STOP-SHOP MODEL FOR THE ENERGY TRANSITION
InterviewsROOTED IN ROMANIA, BUILT TO DELIVER TECHNOLOGY FOR THE WORLD - EVANTAGE SOFT MODEL FOR GLOBAL IMPACT
NewsThe New S-Class: Refinement, Innovation and 140 Years of History
NewsSchneider Electric to become the Official Energy Technology Partner of McLaren Racing
NewsVodafone Foundation invests another 1.5 million lei in equipping neonatology units in Romania
BRD-Groupe Societe Generale and UniCredit Bank have granted a syndicated loan of EUR127 million to pharmaceutical group A&D Pharma, for a three-year period. The two banks will have equal contributions to the loan (EUR 63.5 million each).
A&D Pharma will use the money to refinance a syndicated credit line it took in 2013. The pharmaceutical group was assisted by local law firm RTPR Allen & Overy while the two banks’ legal counselor was CMS Romania.
For more information, please see the Romanian version of the article, here.
![2026 consumer trends and industry insights [Webinar]](https://doingbusiness.ro/media/covers/6979dc6c4329e_cover.jpg)
